• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含苯巴比妥的缓释交联壳聚糖微球的制备与评价

Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.

作者信息

al-Helw A A, Al-Angary A A, Mahrous G M, al-Dardari M M

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

出版信息

J Microencapsul. 1998 May-Jun;15(3):373-82. doi: 10.3109/02652049809006864.

DOI:10.3109/02652049809006864
PMID:9608399
Abstract

Chitosan microspheres containing phenobarbitone were successfully prepared by glutaraldehyde cross-linking of an aqueous acetic acid dispersion of chitosan in light liquid paraffin containing sorbitan mono-oleate as a stabilizing agent. Uniform and spherical microspheres, with a loading efficiency up to 57.2%, could be prepared depending on the preparation conditions. The main parameters affecting the preparation and the performance of the prepared microspheres were the molecular weight and concentration of chitosan as well as the concentration of the used stabilizing agent. The incorporation of citric acid into the microspheres was found to increase the formation of a water-soluble gel when the microspheres come in contact with the dissolution medium increasing the rate of drug release. The particle size was shifted towards smaller diameters with increased concentration of sorbitan mono-oleate, up to 4.0% v/v, by use of a lower concentration of chitosan (1.0% w/v) and chitosan with low molecular weight. Rapid initial drug release (20-30% of the incorporated drug) was exhibited in all the prepared microspheres followed by slow release of the remaining amount of the drug. The release rate of the drug from the microspheres prepared from high molecular weight chitosan was slow in comparison with that prepared from medium and low molecular weight chitosan. High concentrations of sorbitan mono-oleate increased the rate of drug release.

摘要

以山梨醇单油酸酯为稳定剂,在轻质液体石蜡中,通过壳聚糖的醋酸水溶液分散体的戊二醛交联成功制备了含苯巴比妥的壳聚糖微球。根据制备条件,可以制备出均匀的球形微球,载药效率高达57.2%。影响微球制备及性能的主要参数是壳聚糖的分子量和浓度以及所用稳定剂的浓度。当微球与溶出介质接触时,发现将柠檬酸掺入微球中会增加水溶性凝胶的形成,从而提高药物释放速率。通过使用较低浓度的壳聚糖(1.0% w/v)和低分子量壳聚糖,随着山梨醇单油酸酯浓度增加至4.0% v/v,粒径向较小直径方向移动。所有制备的微球均表现出快速的初始药物释放(占掺入药物的20 - 30%),随后是剩余药物的缓慢释放。与由中、低分子量壳聚糖制备的微球相比,由高分子量壳聚糖制备的微球中药物的释放速率较慢。高浓度的山梨醇单油酸酯提高了药物释放速率。

相似文献

1
Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.含苯巴比妥的缓释交联壳聚糖微球的制备与评价
J Microencapsul. 1998 May-Jun;15(3):373-82. doi: 10.3109/02652049809006864.
2
Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.通过膜乳化技术制备均匀尺寸的壳聚糖微球及其作为蛋白质药物载体的应用。
J Control Release. 2005 Aug 18;106(1-2):62-75. doi: 10.1016/j.jconrel.2005.04.005.
3
Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman.用于炔诺酮肟控释的戊二醛交联壳聚糖微球
Carbohydr Res. 2007 Nov 5;342(15):2244-52. doi: 10.1016/j.carres.2007.06.009. Epub 2007 Jun 12.
4
Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.喷雾干燥法制备的载卡马西平壳聚糖和羟丙基甲基纤维素微球:制备与表征
J Pharm Pharmacol. 2003 Jul;55(7):921-31. doi: 10.1211/0022357021503.
5
5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.载有5-氟尿嘧啶的壳聚糖微球:制备及释放特性
J Microencapsul. 1996 Mar-Apr;13(2):161-8. doi: 10.3109/02652049609052904.
6
Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique.硬脂酸镁对采用乳化凝聚法制备的壳聚糖微球的影响。
J Microencapsul. 1998 May-Jun;15(3):319-33. doi: 10.3109/02652049809006860.
7
Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.用于炔诺酮肟控释的戊二醛和乙二醛交联壳聚糖微球
Carbohydr Res. 2006 May 1;341(6):744-56. doi: 10.1016/j.carres.2006.02.003. Epub 2006 Feb 24.
8
Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process.通过膜乳化和两步固化法制备及表征含胰岛素的均匀尺寸壳聚糖微球。
Colloids Surf B Biointerfaces. 2006 Jul 1;50(2):126-35. doi: 10.1016/j.colsurfb.2006.05.006. Epub 2006 May 19.
9
Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.用于药物递送应用的交联壳聚糖微球的合成与表征
J Microencapsul. 2003 May-Jun;20(3):375-85. doi: 10.1080/0265204031000093078.
10
Preparation of gelatin microspheres containing lactic acid--effect of cross-linking on drug release.含乳酸明胶微球的制备——交联对药物释放的影响
Acta Pharm. 2005 Mar;55(1):57-67.

引用本文的文献

1
Self-Healing Injectable Hydrogels for Tissue Regeneration.用于组织再生的自修复可注射水凝胶。
Chem Rev. 2023 Jan 25;123(2):834-873. doi: 10.1021/acs.chemrev.2c00179. Epub 2022 Aug 5.
2
Chitosan microspheres in novel drug delivery systems.新型药物递送系统中的壳聚糖微球
Indian J Pharm Sci. 2011 Jul;73(4):355-66. doi: 10.4103/0250-474X.95607.
3
Two-stage optimization process for formulation of chitosan microspheres.壳聚糖微球制剂的两阶段优化过程
AAPS PharmSciTech. 2004 Feb 6;5(1):E5. doi: 10.1208/pt050105.
4
Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.壳聚糖对5-氟尿嘧啶诱导的小鼠骨髓毒性、胃肠道毒性和免疫活性器官毒性的预防作用,且不丧失其抗肿瘤活性。
Jpn J Cancer Res. 1999 Jul;90(7):765-74. doi: 10.1111/j.1349-7006.1999.tb00813.x.